PRDM1-mediated epigenetic and transcriptional repression mechanisms: a key hub in immune differentiation, tumor progression, and inflammatory responses - Report - MDSpire

PRDM1-mediated epigenetic and transcriptional repression mechanisms: a key hub in immune differentiation, tumor progression, and inflammatory responses

  • By

  • Zongliang Xu

  • Shiyuan Liu

  • Yizhuo Fu

  • Yuqin Zhang

  • Wenzhi Shen

  • Huan Liu

  • June 18, 2026

  • 0 min

Share

Clinical Report: Mechanisms of Epigenetic and Transcriptional Repression by PRDM1

Overview

PRDM1 is a transcriptional repressor involved in immune cell differentiation and tumor suppression. Its dysregulation is linked to various cancers and autoimmune diseases.

Background

PRDM1 plays a role in B- and T-cell differentiation and immune regulation, which is significant in maintaining immune homeostasis. Its involvement in tumor suppression and progression is noted in cancer biology.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • PRDM1 functions as a transcriptional repressor through its C2H2 zinc finger domains.
  • It recruits co-repressors like G9a and HDACs to mediate transcriptional repression.
  • PRDM1 is implicated in the regulation of tumor suppression and metastasis in various cancers.
  • Dysregulation of PRDM1 is associated with autoimmune diseases such as lupus and rheumatoid arthritis.

Clinical Implications

Understanding PRDM1's role in immune regulation and tumor biology is important.

Conclusion

PRDM1 is a regulator in immune and cancer biology.

Related Resources & Content

  1. Blood Cancer Journal, 2014 -- The Impact of Epigenetic Mechanisms on Multiple Myeloma Pathophysiology
  2. Basic Research in Cardiology, 2013 -- Epigenetic Mechanisms: A Novel Approach to Understanding Heart Failure Regulation?
  3. Blood Cancer Journal, 2025 -- The Role of Transposable Elements in Regulating Genomic Activity During Normal and Cancerous Hematopoiesis
  4. Blood Cancer Journal, 2021 -- Targeting the Inflammasome for Therapy in Myeloid Cancers
  5. Nature Immunology, 2024 -- Blimp-1 and c-Maf regulate immune gene networks to protect against distinct pathways of pathobiont-induced colitis
  6. https://findresearcher.sdu.dk/ws/portalfiles/portal/141804722/Loss_of_PRDM1_BLIMP_1_function_contributes_to_poor_prognosis_of_activated_B_cell_like_diffuse_large_B_cell_lymphoma.pdf
  7. Blimp-1 and c-Maf regulate immune gene networks to protect against distinct pathways of pathobiont-induced colitis | Nature Immunology

Original Source(s)

PRDM1-mediated epigenetic and transcriptional repression mechanisms: a key hub in immune differentiation, tumor progression, and inflammatory responses

  • by Zongliang Xu, Shiyuan Liu, Yizhuo Fu, Yuqin Zhang, Wenzhi Shen, Huan Liu

  • June 18, 2026

Related Content

Coencapsulation of doxorubicin and curcumin in liposomes modified with folic acid for reversal of drug resistance in glioma

Temporal dynamics and determinants of early recurrence after curative resection for stage I-III rectal cancer: integrated analyses of hazard function, survival, and competing risks

HuBIE: The human blood immunome encyclopedia of TCRs and BCRs in bloodstream infections and cancer